Xenofon Baraliakos (X Baraliakos)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 110

Top Venues

Annals of the rheumatic diseases

RMD open

The Journal of rheumatology

Arthritis & rheumatology (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy (2023)
Elenore Judy B Uy, Jie Kie Phang, Ting Hui Woon, Jean W Liew, M Hassan Murad, Fabian Proft, Josef S Smolen, Anna Moltó, Victoria Navarro-Compán, Manouk de Hooge, Bhowmik Meghnathi, Nelly Ziadé, Sizheng Steven Zhao, Maria Llop, Xenofon Baraliakos, Weng Seng Warren Fong
Social Media Use Among Members of the Assessment of Spondyloarthritis International Society: Results of a Web-Based Survey. Journal of medical Internet research 25 (2023)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy 23 (2) (2023)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaçi, Thilo Klopsch, Anja Plenske, Lisa K Blindzellner, Pascal Klaus, Thomas Meng, Peter-Andreas Löschmann
Correction: Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes. Rheumatology and therapy (2023)
Andreas Reich, Anja Weiß, Lisa Lindner, Xenofon Baraliakos, Denis Poddubnyy, Silke Zinke, Carsten Stille, Anja Strangfeld, Anne Constanze Regierer
Depressive symptoms are associated with fatigue, poorer functional status and less engagement in sports in axSpA and PsA: an analysis from the RABBIT-SpA cohort. Arthritis research & therapy 25 (1) (2023)
Désirée Mfm van der Heijde, Atul A Deodhar, Xenofon Baraliakos, Matthew A Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S Gensler, Nigil Haroon, Marina Magrey, Walter P Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip E Van den Bosch, Thomas Vaux, Huji Xu
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Annals of the rheumatic diseases (2023)
Xenofon Baraliakos, Atul A Deodhar, Désirée Mfm van der Heijde, Marina Magrey, Walter P Maksymowych, Tetsuya Tomita, Huji Xu, Ute Massow, Carmen Fleurinck, Alicia M Ellis, Thomas Vaux, Julie Shepherd-Smith, Alexander Marten, Lianne S Gensler
Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies. Annals of the rheumatic diseases (2023)
Elenore Judy B Uy, Jie Kie Phang, Ting Hui Woon, Jean W Liew, M Hassan Murad, Fabian Proft, Josef S Smolen, Anna Moltó, Victoria Navarro-Compán, Manouk de Hooge, Bhowmik Meghnathi, Nelly Ziadé, Sizheng Steven Zhao, Maria Llop, Xenofon Baraliakos, Weng Seng Warren Fong
Social Media Use Among Members of the Assessment of Spondyloarthritis International Society: Results of a Web-Based Survey. Journal of medical Internet research 25 (2023)
Elenore Judy B Uy, Jie Kie Phang, Ting Hui Woon, Jean W Liew, M Hassan Murad, Fabian Proft, Josef S Smolen, Anna Moltó, Victoria Navarro-Compán, Manouk de Hooge, Bhowmik Meghnathi, Nelly Ziadé, Sizheng Steven Zhao, Maria Llop, Xenofon Baraliakos, Weng Seng Warren Fong
Social Media Use Among Members of the Assessment of Spondyloarthritis International Society: Results of a Web-Based Survey. Journal of medical Internet research 25 (2023)
Kevin L Winthrop, John Dudley Isaacs, Phillip J Mease, Dimitrios T Boumpas, Xenofon Baraliakos, Jacques-Eric Gottenberg, Stefan Siebert, Marta Mosca, Neil Basu, Dana Orange, R Lories, Daniel Aletaha, Iain B McInnes, Thomas Wj Huizinga, Reinhard E Voll, Ellen M Gravallese, Ferry C Breedveld, Josef S Smolen
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022. Annals of the rheumatic diseases (2023)
Alen Zabotti, Gabriele De Marco, Laure Gossec, Xenofon Baraliakos, Daniel Aletaha, AnnaMaria Iagnocco, Paolo Gisondi, Peter V Balint, Heidi Bertheussen, Wolf-Henning Boehncke, Nemanja S Damjanov, Maarten P T de Wit, Enzo Errichetti, Helena Marzo-Ortega, Mikhail Protopopov, Lluis Puig, Rubén Queiro, Roberto Caporali, Laura Savage, Larissa Valor-Méndez, Stefan Siebert, Tanja Alexandra Stamm, Paul Studenic, Ilaria Tinazzi, Filip E Van den Bosch, Annette van der Helm-van Mil, Giovanni Damiani, Josef S Smolen, Dennis G McGonagle
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis. Annals of the rheumatic diseases (2023)
Raphael Micheroli, Seraphina Kissling, Kristina Bürki, Burkhard Möller, Axel Finckh, Michael John Nissen, Pascale Exer, René Bräm, Diego Kyburz, Andrea Rubbert-Roth, Michael Andor, Xenofon Baraliakos, Manouk de Hooge, Oliver Distler, Almut Scherer, Adrian Ciurea
Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry. Clinical rheumatology (2023)
Matthias Augustin, Lisa Lindner, Laura Kühl, Anja Weiß, Stephan Jeff Rustenbach, Brigitte Stephan, Martin Feuchtenberger, Ulrich Mrowietz, Diamant Thaçi, Petra Staubach, Xenofon Baraliakos, Anja Strangfeld, Ralph von Kiedrowski, Frank Behrens, Anne Constanze Regierer
Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registries. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2023)
David Kiefer, Jüergen Braun, Uta Kiltz, Varvara Chatzistefanidi, Daniela Adolf, Ilka Schwarze, Maria Kabelitz, Uwe Lange, Jan Brandt-Jürgens, Edgar Stemmler, Sabine Sartingen, Xenofon Baraliakos
Global functioning in axial spondyloarthritis is stronger associated with disease activity and function than with mobility and radiographic damage. Arthritis care & research (2023)
Anne Constanze Regierer, Anja Weiß, Fabian Proft, Xenofon Baraliakos, Frank Behrens, Denis Poddubnyy, Georg Schett, Hanns-Martin Lorenz, Matthias Worsch, Anja Strangfeld
Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA. RMD open 9 (1) (2023)
Victoria Navarro-Compán, Xenofon Baraliakos, Marina N Magrey, Andrew Östör, Christopher D Saffore, Manish Mittal, In-Ho Song, Fabiana Ganz, Jayne Stigler, Atul A Deodhar
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis. Rheumatology and therapy (2023)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Rosalinde Stal, Xenofon Baraliakos, Jüergen Braun, Monique Reijnierse, Caroline Bastiaenen, Josef S Smolen, Floris A van Gaalen
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis. RMD open 9 (1) (2023)
Rosalinde Stal, Josef S Smolen, Désirée Mfm van der Heijde, Floris A van Gaalen, Xenofon Baraliakos, Pedro M Machado, Manouk de Hooge, Rosaline van den Berg, Monique Reijnierse, Jüergen Braun, Robert B M Landewé, Alexandre Sepriano
Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trial. RMD open 9 (3) (2023)
Kevin L Winthrop, John Dudley Isaacs, Phillip J Mease, Dimitrios T Boumpas, Xenofon Baraliakos, Jacques-Eric Gottenberg, Stefan Siebert, Marta Mosca, Neil Basu, Dana Orange, R Lories, Daniel Aletaha, Iain B McInnes, Thomas Wj Huizinga, Reinhard E Voll, Ellen M Gravallese, Ferry C Breedveld, Josef S Smolen
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022. Annals of the rheumatic diseases (2023)
Matthias Augustin, Lisa Lindner, Laura Kühl, Anja Weiß, Stephan Jeff Rustenbach, Brigitte Stephan, Martin Feuchtenberger, Ulrich Mrowietz, Diamant Thaçi, Petra Staubach, Xenofon Baraliakos, Anja Strangfeld, Ralph von Kiedrowski, Frank Behrens, Anne Constanze Regierer
Charakterisierung von Patienten mit Psoriasisarthritis in der dermatologischen und rheumatologischen Versorgung: Analyse von zwei Registern: Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registries. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 21 (10) (2023)
Victoria Navarro-Compán, Xenofon Baraliakos, Marina N Magrey, Andrew Östör, Christopher D Saffore, Manish Mittal, In-Ho Song, Fabiana Ganz, Jayne Stigler, Atul A Deodhar
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis. Rheumatology and therapy (2023)
Gabriele de Marco, Alen Zabotti, Xenofon Baraliakos, AnnaMaria Iagnocco, Daniel Aletaha, Paulo Gisondi, Jenny Emmel, Josef S Smolen, Dennis G McGonagle, Laure Gossec
Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforce. RMD open 9 (2) (2023)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy 23 (2) (2023)
Caroline Ensslin, Raphael Micheroli, Seraphina Kissling, Andrea Götschi, Kristina Bürki, René Bräm, Manouk de Hooge, Xenofon Baraliakos, Michael John Nissen, Burkhard Möller, Pascale Exer, Michael Andor, Oliver Distler, Almut Scherer, Adrian Ciurea
Impact of sex on spinal radiographic progression in axial spondyloarthritis: a longitudinal Swiss cohort analysis over a period of 10 years. RMD open 9 (3) (2023)
Xenofon Baraliakos, Roberto Ranza, Andrew Östör, Francesco Ciccia, Laura C Coates, Simona Rednic, Jessica A Walsh, Kevin Douglas, Tianming Gao, Koji Kato, In-Ho Song, Fabiana Ganz, Atul Deodhar
Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies. Arthritis research & therapy 25 (1) (2023)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy (2023)
Désirée Mfm van der Heijde, Atul A Deodhar, Xenofon Baraliakos, Matthew A Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S Gensler, Nigil Haroon, Marina Magrey, Walter P Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip E Van den Bosch, Thomas Vaux, Huji Xu
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Annals of the rheumatic diseases (2023)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Rosalinde Stal, Xenofon Baraliakos, Jüergen Braun, Monique Reijnierse, Caroline Bastiaenen, Josef S Smolen, Floris A van Gaalen
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis. RMD open 9 (1) (2023)
Phillip J Mease, Dafna D Gladman, Denis Poddubnyy, Soumya D Chakravarty, May Shawi, Alexa P Kollmeier, Xie L Xu, Stephen Xu, Atul Deodhar, Xenofon Baraliakos
Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study. Rheumatology and therapy (2023)
Gabriele de Marco, Alen Zabotti, Xenofon Baraliakos, AnnaMaria Iagnocco, Daniel Aletaha, Paulo Gisondi, Jenny Emmel, Josef S Smolen, Dennis G McGonagle, Laure Gossec
Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforce. RMD open 9 (2) (2023)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Rosalinde Stal, Xenofon Baraliakos, Jüergen Braun, Monique Reijnierse, Caroline Bastiaenen, Josef S Smolen, Floris A van Gaalen
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis. RMD open 9 (1) (2023)
Xenofon Baraliakos, Désirée van der Heijde, Joachim Sieper, Robert D Inman, Hideto Kameda, Yihan Li, Xianwei Bu, Anna Shmagel, Peter Wung, In-Ho Song, Atul Deodhar
Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study. Arthritis research & therapy 25 (1) (2023)
Jiancong Wang, Sabrina Tulka, Stephanie Knippschild, Matthias Schneider, Jörg H W Distler, Xenofon Baraliakos, Ralph Brinks, Philipp Sewerin
A population-based projection of psoriatic arthritis in Germany until 2050: analysis of national statutory health insurance data of 65 million German population. Rheumatology international (2023)
Alessia Alunno, Tadej Avcin, Catherine Haines, Josef S Smolen, Francisca Sivera, Sara Badreh, Xenofon Baraliakos, Johannes W J Bijlsma, Frank Buttgereit, Kaushik Chaudhuri, José António Pereira Da Silva, Jean Dudler, Ricardo Jorge de Oliveira Ferreira, Tania Gudu, Eric Hachulla, Mette Holland-Fischer, AnnaMaria Iagnocco, Tue Wenzel Kragstrup, György Nagy, Vasco C Romão, Simon R Stones, Marloes van Onna, Christopher J Edwards
Points to consider: EULAR-UEMS standards for the training of European rheumatologists. Annals of the rheumatic diseases (2023)
Arthur Kavanaugh, Xenofon Baraliakos, Sheng Gao, Warner Chen, Kristen M Sweet, Soumya D Chakravarty, Qingxuan Song, May Shawi, Proton Rahman
Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials. Advances in therapy (2023)
Elenore Judy B Uy, Jie Kie Phang, Ting Hui Woon, Jean W Liew, M Hassan Murad, Fabian Proft, Josef S Smolen, Anna Moltó, Victoria Navarro-Compán, Manouk de Hooge, Bhowmik Meghnathi, Nelly Ziadé, Sizheng Steven Zhao, Maria Llop, Xenofon Baraliakos, Weng Seng Warren Fong
Social Media Use Among Members of the Assessment of Spondyloarthritis International Society: Results of a Web-Based Survey. Journal of medical Internet research 25 (2023)
Elenore Judy B Uy, Jie Kie Phang, Ting Hui Woon, Jean W Liew, M Hassan Murad, Fabian Proft, Josef S Smolen, Anna Moltó, Victoria Navarro-Compán, Manouk de Hooge, Bhowmik Meghnathi, Nelly Ziadé, Sizheng Steven Zhao, Maria Llop, Xenofon Baraliakos, Weng Seng Warren Fong
Social Media Use Among Members of the Assessment of Spondyloarthritis International Society: Results of a Web-Based Survey. Journal of medical Internet research 25 (2023)
Kevin L Winthrop, John Dudley Isaacs, Phillip J Mease, Dimitrios T Boumpas, Xenofon Baraliakos, Jacques-Eric Gottenberg, Stefan Siebert, Marta Mosca, Neil Basu, Dana Orange, R Lories, Daniel Aletaha, Iain B McInnes, Thomas Wj Huizinga, Reinhard E Voll, Ellen M Gravallese, Ferry C Breedveld, Josef S Smolen
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022. Annals of the rheumatic diseases (2023)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy 23 (2) (2023)
Ioana Andreica, Iulia Roman, Imke Redeker, Xenofon Baraliakos, Jüergen Braun, Uta Kiltz
Facilitators and barriers for vaccination in patients with inflammatory rheumatic musculoskeletal diseases: a prospective cohort study. RMD open 9 (2) (2023)
Elenore Judy B Uy, Jie Kie Phang, Ting Hui Woon, Jean W Liew, M Hassan Murad, Fabian Proft, Josef S Smolen, Anna Moltó, Victoria Navarro-Compán, Manouk de Hooge, Bhowmik Meghnathi, Nelly Ziadé, Sizheng Steven Zhao, Maria Llop, Xenofon Baraliakos, Weng Seng Warren Fong
Social Media Use Among Members of the Assessment of Spondyloarthritis International Society: Results of a Web-Based Survey. Journal of medical Internet research 25 (2023)
Victoria Navarro-Compán, Diego Benavent, Dafne Capelusnik, Désirée Mfm van der Heijde, Robert B M Landewé, Denis Poddubnyy, Astrid van Tubergen, Xenofon Baraliakos, Filip E Van den Bosch, Floris A van Gaalen, Lianne S Gensler, Clementina López Medina, Helena Marzo-Ortega, Anna Moltó, Rodolfo Pérez-Alamino, Martin Rudwaleit, Marleen van de Sande, Alice Heaney, Ulrich Weber, Josef S Smolen
ASAS consensus definition of early axial spondyloarthritis. Annals of the rheumatic diseases (2023)
Josef S Smolen, Elena Nikiphorou, Alexandre Sepriano, Augusta Ortolan, Casper Webers, Xenofon Baraliakos, Robert B M Landewé, Désirée Mfm van der Heijde
Response to: Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update" by Ramiro et al . Annals of the rheumatic diseases (2023)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Rosalinde Stal, Xenofon Baraliakos, Jüergen Braun, Monique Reijnierse, Caroline Bastiaenen, Josef S Smolen, Floris A van Gaalen
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis. RMD open 9 (1) (2023)
Dafna D Gladman, Phillip J Mease, Paul Bird, Enrique Roberto Soriano, Soumya D Chakravarty, May Shawi, Frederic Lavie, Cinty Gong, Evan Leibowitz, Denis Poddubnyy, Lai Shan Tam, Philip S Helliwell, Arthur Kavanaugh, Atul A Deodhar, Mikkel Østergaard, Xenofon Baraliakos
Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?' by Braun and Landewé. Annals of the rheumatic diseases (2022)
Xenofon Baraliakos, Christoph Rischpler, Nils-Martin Bruckmann
Response to the comment by de Jongh et al on the article: Effects of anti-TNF-therapy on inflammatory, structural and osteoblastic activity lesions in radiographic axial spondyloarthritis. Arthritis & rheumatology (Hoboken, N.J.) (2022)
Uta Kiltz, Eerik Ahomaa, Salima F E van Weely, David Kiefer, Bjoern Bühring, Xenofon Baraliakos, Jüergen Braun
Clinically Relevant Deficits in Performance Tests in Patients With Axial Spondyloarthritis. The Journal of rheumatology (2022)
Dafna D Gladman, Philip J Mease, Paul Bird, Enrique Roberto Soriano, Soumya D Chakravarty, May Shawi, Stephen Xu, Sean T Quinn, Cinty Gong, Evan Leibowitz, Denis Poddubnyy, Lai-Shan Tam, Philip S Helliwell, Arthur Kavanaugh, Atul Deodhar, Mikkel Østergaard, Xenofon Baraliakos
Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial. Trials 23 (1) (2022)
Xenofon Baraliakos, Effie Pournara, Laure Gossec, Phillip J Mease, Roisin White, Eamonn O'Brien, Barbara Schulz, Helena Marzo-Ortega, Laura C Coates
Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial. RMD open 8 (2) (2022)
Casper Webers, Augusta Ortolan, Alexandre Sepriano, Louise Falzon, Xenofon Baraliakos, Robert B M Landewé, Josef S Smolen, Désirée Mfm van der Heijde, Elena Nikiphorou
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis. Annals of the rheumatic diseases (2022)
Bjoern Bühring, Nadine Al-Azem, Uta Kiltz, Martin Fruth, Ioana Andreica, David Kiefer, Styliani Tsiami, Xenofon Baraliakos, Jüergen Braun
High Prevalence of Foot Insufficiency Fractures in Patients With Inflammatory Rheumatic Musculoskeletal Diseases. The Journal of rheumatology (2022)
Iain B McInnes, AnnaMaria Iagnocco, Daniel Aletaha, Xenofon Baraliakos, Johannes W J Bijlsma, Elsa F Mateus, Zoltán Szekanecz, Thea P M Vliet Vlieland, Josef S Smolen
Reflections on a contemporary European tragedy. Annals of the rheumatic diseases 81 (6) (2022)
Rosalinde Stal, Xenofon Baraliakos, Désirée Mfm van der Heijde, Floris A van Gaalen, Josef S Smolen, Rosaline van den Berg, Monique Reijnierse, Jüergen Braun, Robert B M Landewé, Alexandre Sepriano
Role of vertebral corner inflammation and fat deposition on MRI on syndesmophyte development detected on whole spine low-dose CT scan in radiographic axial spondyloarthritis. RMD open 8 (2) (2022)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Monique Reijnierse, Xenofon Baraliakos, Jüergen Braun, Floris A van Gaalen, Josef S Smolen
Low-dose CT hounsfield units: a reliable methodology for assessing vertebral bone density in radiographic axial spondyloarthritis. RMD open 8 (2) (2022)
Rosalinde Stal, Alexandre Sepriano, Floris Alexander van Gaalen, Xenofon Baraliakos, Rosaline van den Berg, Monique Reijnierse, Jüergen Braun, Robert B M Landewé, Désirée Mfm van der Heijde
Associations between syndesmophytes and facet joint ankylosis in radiographic axial spondyloarthritis patients on low-dose CT over 2 years. Rheumatology (Oxford, England) 61 (12) (2022)
Iain B McInnes, Andrew J K Ostor, Phillip J Mease, William Tillett, Xenofon Baraliakos, Kurt de Vlam, Louis Bessette, Ralph Lippe, Anna Maniccia, Dai Feng, Tianming Gao, Patrick Zueger, Christopher Saffore, Koji Kato, In-Ho Song, Atul Deodhar
Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials. RMD open 8 (1) (2022)
Adrian Ciurea, Seraphina Kissling, Kristina Bürki, Xenofon Baraliakos, Manouk de Hooge, Monika Hebeisen, Eleftherios Papagiannoulis, Pascale Exer, René Bräm, Michael J Nissen, Burkhard Möller, Diego Kyburz, Michael Andor, Oliver Distler, Almut Scherer, Raphael Micheroli
Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort. RMD open 8 (1) (2022)
Walter P Maksymowych, Rebecca Bolce, Gaia Gallo, Emily Seem, Vladimir J Geneus, David M Sandoval, Mikkel Østergaard, Kurisu Tada, Xenofon Baraliakos, Atul Deodhar, Lianne S Gensler
Ixekizumab in radiographic axial spondyloarthritis with and without elevated C-reactive protein or positive magnetic resonance imaging. Rheumatology (Oxford, England) 61 (11) (2022)
Martin Krekeler, Xenofon Baraliakos, Styliani Tsiami, Jüergen Braun
High prevalence of chondrocalcinosis and frequent comorbidity with calcium pyrophosphate deposition disease in patients with seronegative rheumatoid arthritis. RMD open 8 (2) (2022)
Keno Kyrill Bressem, Lisa C Adams, Fabian Proft, Kay Geert A Hermann, Torsten Diekhoff, Laura Spiller, Stefan Markus Niehues, Marcus R Makowski, Bernd Hamm, Mikhail Protopopov, Valeria Rios Rodriguez, Hildrun Haibel, Judith Rademacher, Murat Torğutalp, Robert G W Lambert, Xenofon Baraliakos, Walter P Maksymowych, Janis Lucas Vahldiek, Denis Poddubnyy
Deep Learning Detects Changes Indicative of Axial Spondyloarthritis at MRI of Sacroiliac Joints. Radiology 305 (3) (2022)
Xenofon Baraliakos, Atul A Deodhar, Maxime Dougados, Lianne S Gensler, Anna Molto, Josef S Smolen, Alan J Kivitz, Denis Poddubnyy, Marga Oortgiesen, Thomas Vaux, Carmen Fleurinck, Julie Shepherd-Smith, Christine de la Loge, Natasha de Peyrecave, Désirée van der Heijde
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study. Arthritis & rheumatology (Hoboken, N.J.) (2022)
Philipp Bosch, Francesco Carubbi, And Carlo Alberto Scirè, Xenofon Baraliakos, Louise Falzon, Christian Dejaco, Pedro M Machado
Value of imaging to guide interventional procedures in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 7 (3) (2022)
Imke Redeker, Anja Strangfeld, Johanna Callhoff, Ursula Marschall, Angela Zink, Xenofon Baraliakos
Maternal and infant outcomes in pregnancies of women with axial spondyloarthritis compared with matched controls: results from nationwide health insurance data. RMD open 8 (2) (2022)
Charles G Peterfy, Vibeke Strand, Alan Friedman, Stephen Hall, Eduardo Mysler, Patrick Durez, Xenofon Baraliakos, Jeffrey V Enejosa, Tim Shaw, Yihan Li, Su Chen, In-Ho Song
Inhibition of structural joint damage progression with upadacitinib in rheumatoid arthritis: 1-year outcomes from the SELECT phase 3 program. Rheumatology (Oxford, England) 61 (8) (2022)
Désirée Mfm van der Heijde, Xenofon Baraliakos, Joachim Sieper, Atul A Deodhar, Robert D Inman, Hideto Kameda, Xiaofeng Zeng, Yunxia Sui, Xianwei Bu, Aileen L Pangan, Peter Wung, In-Ho Song
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial. Annals of the rheumatic diseases 81 (11) (2022)
Xenofon Baraliakos, Mikkel Østergaard, Robert Gw Lambert, Iris Eshed, Pedro M Machado, Susanne Juhl Pedersen, Ulrich Weber, Manouk de Hooge, Joachim Sieper, Denis Poddubnyy, Martin Rudwaleit, Désirée Mfm van der Heijde, Robert B M Landewé, Walter P Maksymowych
MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group. Annals of the rheumatic diseases (2022)
Uta Kiltz, Eerik P Ahomaa, Salima F E van Weely, David Kiefer, Bjoern Bühring, Xenofon Baraliakos, Jüergen Braun
Clinically Relevant Deficits in Performance Tests in Patients With Axial Spondyloarthritis. The Journal of rheumatology 50 (3) (2022)
Dietmar Krause, Anna Mai, Renate Klaassen-Mielke, Nina Timmesfeld, Ulrike Trampisch, Henrik Rudolf, Xenofon Baraliakos, Elmar Schmitz, Claas Fendler, Claudia Klink, Stephanie Boeddeker, Ertan Saracbasi-Zender, Hans-Joachim Christoph, Manfred Igelmann, Hans-Juergen Menne, Albert Schmid, Rolf Rau, Siegfried Wassenberg, Nilüfer Sonuc, Claudia Ose, Carmen Schade-Brittinger, Hans J Trampisch, Jüergen Braun
The Efficacy of Short-Term Bridging Strategies With High- and Low-Dose Prednisolone on Radiographic and Clinical Outcomes in Active Early Rheumatoid Arthritis: A Double-Blind, Randomized, Placebo-Controlled Trial. Arthritis & rheumatology (Hoboken, N.J.) 74 (10) (2022)
Kalliopi Klavdianou, Styliani Tsiami, Xenofon Baraliakos
New developments in ankylosing spondylitis-status in 2021. Rheumatology (Oxford, England) 60 (Suppl 6) (2022)
Benedikt Kamp, Michael Frenken, Lena Klein-Schmeink, Armin M Nagel, Lena Marie Wilms, Karl Ludger Radke, Styliani Tsiami, Philipp Sewerin, Xenofon Baraliakos, Gerald Antoch, Daniel B Abrar, Hans-Jörg Wittsack, Anja Müller-Lutz
Evaluation of Sodium Relaxation Times and Concentrations in the Achilles Tendon Using MRI. International journal of molecular sciences 23 (18) (2022)
Nils-Martin Bruckmann, Christoph Rischpler, Styliani Tsiami, Julian Kirchner, Daniel B Abrar, Timo Bartel, Jens Theysohn, Lale Umutlu, Ken Herrmann, Wolfgang P Fendler, Christian Buchbender, Gerald Antoch, Lino M Sawicki, Athanasios Tsobanelis, Juergen Braun, Xenofon Baraliakos
Effects of Anti-Tumor Necrosis Factor Therapy on Osteoblastic Activity at Sites of Inflammatory and Structural Lesions in Radiographic Axial Spondyloarthritis: A Prospective Proof-of-Concept Study Using Positron Emission Tomography/Magnetic Resonance Imaging of the Sacroiliac Joints and Spine. Arthritis & rheumatology (Hoboken, N.J.) 74 (9) (2022)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Management of Axial Spondyloarthritis - Insights into Upadacitinib. Drug design, development and therapy 16 (2022)
Elena Schwendich, Laura Salinas Tejedor, Gernot Schmitz, Markus Rickert, Juergen Steinmeyer, Stefan Rehart, Styliani Tsiami, Jürgen Braun, Xenofon Baraliakos, Jörg Reinders, Elena Neumann, Ulf Müller-Ladner, Silvia Capellino
Modulation of Dopamine Receptors on Osteoblasts as a Possible Therapeutic Strategy for Inducing Bone Formation in Arthritis. Cells 11 (10) (2022)
Robin Kempin, Jutta G Richter, Anna Schlegel, Xenofon Baraliakos, Styliani Tsiami, Bjoern Buehring, David Kiefer, Jüergen Braun, Uta Kiltz
Monitoring of Disease Activity With a Smartphone App in Routine Clinical Care in Patients With Axial Spondyloarthritis. The Journal of rheumatology 49 (8) (2022)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaçi, Thilo Klopsch, Anja Plenske, Lisa K Blindzellner, Pascal Klaus, Thomas Meng, Peter-Andreas Löschmann
Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes. Rheumatology and therapy 9 (2) (2022)
Victoria Navarro-Compán, Anne Boel, Annelies Boonen, Phillip J Mease, Maxime Dougados, Uta Kiltz, Robert B M Landewé, Xenofon Baraliakos, Wilson Bautista-Molano, Praveena Chiowchanwisawakit, Hanne Dagfinrud, Lara Fallon, Marco Garrido-Cumbrera, Lianne Gensler, Bassel Kamal ElZorkany, Nigil Haroon, Elenore Judy B Uy, Pedro M Machado, Walter Maksymowych, Anna Moltó, Natasha de Peyrecave, Denis Poddubnyy, Mikhail Protopopov, Josef S Smolen, In-Ho Song, Salima van Weely, Désirée Mfm van der Heijde
Instrument selection for the ASAS core outcome set for axial spondyloarthritis. Annals of the rheumatic diseases (2022)
Uta Kiltz, Eerik P Ahomaa, Salima F E van Weely, David Kiefer, Bjoern Bühring, Xenofon Baraliakos, Jüergen Braun
Clinically Relevant Deficits in Performance Tests in Patients With Axial Spondyloarthritis. The Journal of rheumatology 50 (3) (2022)
Uta Kiltz, Eerik P Ahomaa, Salima F E van Weely, David Kiefer, Bjoern Bühring, Xenofon Baraliakos, Jüergen Braun
Clinically Relevant Deficits in Performance Tests in Patients With Axial Spondyloarthritis. The Journal of rheumatology 50 (3) (2022)
Reuven Mader, Xenofon Baraliakos, Iris Eshed, Irina Novofastovski, Amir Bieber, Jorrit-Jan Verlaan, David Kiefer, Nicola Pappone, Fabiola Atzeni
Imaging of diffuse idiopathic skeletal hyperostosis (DISH). RMD open 6 (1) (2021)
Christian Dejaco, Pedro M Machado, Francesco Carubbi, Philipp Bosch, Lene Terslev, Giorgio Tamborrini, Luca Maria Sconfienza, And Carlo Alberto Scirè, Sebastian Ruetten, Jef van Rompay, Fabian Proft, Costantino Pitzalis, Marina Obradov, Rikke Helene Moe, Vasco V Mascarenhas, Clara Malattia, Andrea Sabine Klauser, Alison Kent, Lennart Jans, Wolfgang Hartung, Hilde Berner Hammer, Christina Duftner, Peter V Balint, Alessia Alunno, Xenofon Baraliakos
EULAR Points to Consider for the use of imaging to guide interventional procedures in patients with rheumatic and musculoskeletal diseases (RMDs). Annals of the rheumatic diseases (2021)
Uta Kiltz, Aylin Celik, Styliani Tsiami, Bjoern Buehring, Xenofon Baraliakos, Ioana Andreica, David Kiefer, Juergen Braun
Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study. RMD open 7 (1) (2021)
Pedro Santos-Moreno, Xenofon Baraliakos, Rodrigo García Salinas
Engagement process for patients with spondyloarthritis: PANLAR early SpA clinics project - centers of excellence. Clinical rheumatology 40 (11) (2021)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Significance of structural changes in the sacroiliac joints of patients with axial spondyloarthritis detected by MRI related to patients symptoms and functioning. Annals of the rheumatic diseases (2021)
Atul A Deodhar, Paula Sliwinska-Stanczyk, Huji Xu, Xenofon Baraliakos, Lianne S Gensler, Dona Fleishaker, Lisy Wang, Joseph Wu, Sujatha Menon, Cunshan Wang, Oluwaseyi Dina, Lara Fallon, Keith S Kanik, Désirée Mfm van der Heijde
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study. Annals of the rheumatic diseases (2021)
Mikhail Protopopov, Fabian Proft, Alexandre Sepriano, Robert Landewé, Désirée van der Heijde, Walter P Maksymowych, Xenofon Baraliakos, Joachim Sieper, Martin Rudwaleit, Denis Poddubnyy
Radiographic sacroiliitis progression in axial spondyloarthritis: central reading of 5 year follow-up data from the Assessment of SpondyloArthritis international Society cohort. Rheumatology (Oxford, England) 60 (5) (2021)
Xenofon Baraliakos, Adrian Richter, Carsten O Schmidt, Juergen Braun
Response to: 'Correspondence on 'Which factors are associated with bone marrow oedema suspicious of axial spondyloarthritis as detected by MRI in the sacroiliac joints and the spine in the general population?' by Su et al. Annals of the rheumatic diseases (2021)
Laura C Coates, Xenofon Baraliakos, Francisco Javier Blanco, Elena Alonso Blanco-Morales, Jurgen Braun, Vinod Chandran, Jose Luis Fernandez-Sueiro, Oliver FitzGerald, Phil Gallagher, Dafna D Gladman, Elena Gubar, Tatiana Korotaeva, Elena Loginova, Ennio Lubrano, Juan Mulero, Jose Pinto-Tasende, Rubén Queiro, Jesús Sanz Sanz, Agnes Szentpetery, Philip S Helliwell
The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA-B27 Status? Arthritis care & research 73 (6) (2021)
Walter P Maksymowych, Mikkel Østergaard, Robert B M Landewé, William Barchuk, Ke Liu, Leen Gilles, Thijs Hendrikx, Robin Besuyen, Xenofon Baraliakos
Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: results from the TORTUGA trial. Rheumatology (Oxford, England) (2021)
Arvind Kaul, Jatin Mistry, Annamaria Iagnocco, Xenofon Baraliakos, Ailsa Bosworth, Iain McNicol
Inequality of access to advanced therapies for patients with inflammatory arthritis: a postcode lottery? Rheumatology advances in practice 5 (3) (2021)
AnnaMaria Iagnocco, Daniel Aletaha, Xenofon Baraliakos, Iain B McInnes
Message from the new EULAR President and Steering Group. Annals of the rheumatic diseases 80 (10) (2021)
Xenofon Baraliakos, A Ghadir, Martin Fruth, Uta Kiltz, Imke Redeker, Jüergen Braun
Which Magnetic Resonance Imaging Lesions in the Sacroiliac Joints Are Most Relevant for Diagnosing Axial Spondyloarthritis? A Prospective Study Comparing Rheumatologists' Evaluations With Radiologists' Findings. Arthritis & rheumatology (Hoboken, N.J.) 73 (5) (2021)
Xenofon Baraliakos, Adrian Richter, Daniel Feldmann, Anne Ott, Robin Buelow, Carsten O Schmidt, Juergen Braun
Which factors are associated with bone marrow oedema suspicious of axial spondyloarthritis as detected by MRI in the sacroiliac joints and the spine in the general population? Annals of the rheumatic diseases (2020)
Xenofon Baraliakos, Adrian Richter, Carsten O Schmidt, Juergen Braun
Response to: 'Frequency of MRI changes suggestive of axial spondyloarthritis in the axial in a large population-based cohort of individuals aged <45 years' by Parperis. Annals of the rheumatic diseases (2020)
Walter P Maksymowych, Susanne Juhl Pedersen, Ulrich Weber, Xenofon Baraliakos, Pedro M Machado, Iris Eshed, Manouk de Hooge, Joachim Sieper, Stephanie Wichuk, Martin Rudwaleit, Désirée Mfm van der Heijde, Robert B M Landewé, Denis Poddubnyy, Mikkel Ostergaard, Robert G W Lambert
Central reader evaluation of MRI scans of the sacroiliac joints from the ASAS classification cohort: discrepancies with local readers and impact on the performance of the ASAS criteria. Annals of the rheumatic diseases 79 (7) (2020)
Yaser M Ali, Fatemah Abutiban, Adel Alawadhi, Ali AlDei, Ahmad Alenizi, Hebah Alhajeri, Adeeba Al-Herz, Waleed Alkandari, Ahmad Dehrab, Eman Hasan, Sawsan Hayat, Aqeel Ghanem, Khulood Saleh, Xenofon Baraliakos
Recommendation for the Management of Spondyloarthritis Patients in Kuwait. Open access rheumatology : research and reviews 12 (2020)
Xenofon Baraliakos, Mikkel Østergaard, Lianne S Gensler, Denis Poddubnyy, Eun Young Lee, Uta Kiltz, Ruvie Martin, Hiroshi Sawata, Aimee Readie, Brian Porter, null null
Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS). Clinical drug investigation 40 (3) (2020)
Xenofon Baraliakos, Lianne S Gensler, Salvatore D'Angelo, Florenzo Iannone, Ennio G Favalli, Natasha de Peyrecave, Simone E Auteri, Roberto Caporali
Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review. Therapeutic advances in musculoskeletal disease 12 (2020)
Désirée Mfm van der Heijde, Lianne S Gensler, Atul Deodhar, Xenofon Baraliakos, Denis Poddubnyy, Alan Kivitz, Mary Katherine Farmer, Dominique Baeten, Nadine Goldammer, Jason Coarse, Marga Oortgiesen, Maxime Dougados
Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study. Annals of the rheumatic diseases 79 (5) (2020)
Xenofon Baraliakos, Laure Gossec, Iain McInnes, Andreas Kerschbaumer, Maarten P T de Wit, Maxime Dougados, Jette Primdahl, Désirée Mfm van der Heijde, Josef S Smolen
Response to: 'Correspondence on 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Fallon et al. Annals of the rheumatic diseases (2020)
Francisca Sivera, Alessia Alunno, Aurélie Najm, Tadej Avcin, Xenofon Baraliakos, Johannes W Bijlsma, Sara Badreh, Gerd Burmester, Nada Cikes, José António Pereira Da Silva, Nemanja Damjanov, Maxime Dougados, Jean Dudler, Christopher J Edwards, Annamaria Iagnocco, Frédéric Lioté, Elena Nikiphorou, Marloes van Onna, Simon R Stones, Dimitrios Vassilopoulos, Catherine Haines, Josef S Smolen
2019 EULAR points to consider for the assessment of competences in rheumatology specialty training. Annals of the rheumatic diseases 80 (1) (2020)

Xenofon Baraliakos.css-eqlu8i{font-size:small;padding-left:4px;} (X Baraliakos)

Publication Activity (10 Years)

Top Topics

Top Venues

Xenofon Baraliakos (X Baraliakos)